| scholarly article | Q13442814 |
| P2093 | author name string | Mori K | |
| Nakamura H | |||
| Hirota K | |||
| Murata M | |||
| Takeuchi J | |||
| Yodoi J | |||
| Sachi Y | |||
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| cytoplasm | Q79899 | ||
| P304 | page(s) | 27891-27897 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. | |
| P478 | volume | 274 |
| Q40743830 | 1-O-hexyl-2,3,5-trimethylhydroquinone inhibits IkappaB phosphorylation and degradation-linked inducible nitric oxide synthase expression: beyond antioxidant function |
| Q37509298 | 17β-Estradiol alters oxidative stress response protein expression and oxidative damage in the uterus |
| Q99711226 | A Potent Antioxidant Endogenous Neurohormone Melatonin, Rescued MCAO by Attenuating Oxidative Stress-Associated Neuroinflammation |
| Q38383985 | A review on protein-protein interaction network of APE1/Ref-1 and its associated biological functions |
| Q38734522 | APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target |
| Q33990581 | APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions |
| Q35870045 | APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1. |
| Q46265580 | Acetylation Regulates Thioredoxin Reductase Oligomerization and Activity. |
| Q40785651 | Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione |
| Q39771883 | Adrenomedullin protects against hypoxia/reoxygenation-induced cell death by suppression of reactive oxygen species via thiol redox systems |
| Q38328326 | Alcohol-responsive genes in the frontal cortex and nucleus accumbens of human alcoholics |
| Q47148531 | An Extract from the Plant Deschampsia antarctica Protects Fibroblasts from Senescence Induced by Hydrogen Peroxide |
| Q24297014 | An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling |
| Q31877537 | An endogenous redox molecule, thioredoxin, regulates transactivation of epidermal growth factor receptor and activation of NF-kappaB by lysophosphatidic acid. |
| Q43797473 | Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex |
| Q90078100 | Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma |
| Q34830955 | Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors |
| Q39287243 | Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin. |
| Q44023000 | Attenuation of retinal photooxidative damage in thioredoxin transgenic mice. |
| Q28391506 | Basic principles and emerging concepts in the redox control of transcription factors |
| Q39829882 | Biochemical and ultrastructural correlations of calreticulin and thioredoxin expression in breast mucinous carcinoma and infiltrating ductal carcinoma non-special type. |
| Q57748269 | CITRX thioredoxin is a putative adaptor protein connecting Cf-9 and the ACIK1 protein kinase during the Cf-9/Avr9- induced defence response |
| Q37250664 | Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin |
| Q36019198 | Cellular oxidative processes in relation to renal disease |
| Q52567593 | Characterization of Arabidopsis Mutants for the Variable Subunit of Ferredoxin:thioredoxin Reductase. |
| Q28293901 | Characterization of human thioredoxin-like-1: potential involvement in the cellular response against glucose deprivation |
| Q47247894 | Chemical methods for mapping cysteine oxidation. |
| Q39631909 | Chloroethyl urea derivatives block tumour growth and thioredoxin-1 nuclear translocation |
| Q33952980 | Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis |
| Q34387837 | Comparative expression profiling of distinct T cell subsets undergoing oxidative stress |
| Q38634845 | Conferring specificity in redox pathways by enzymatic thiol/disulfide exchange reactions. |
| Q28083118 | Cross Talk between Two Antioxidant Systems, Thioredoxin and DJ-1: Consequences for Cancer |
| Q35347850 | Crosstalk of reactive oxygen species and NF-κB signaling |
| Q89540112 | Crystal structure of thioredoxin 1 from Cryptococcus neoformans at 1.8 Å resolution shows unexpected plasticity of the loop preceding the catalytic site |
| Q37015273 | Cunning factor: macrophage migration inhibitory factor as a redox-regulated target |
| Q40451095 | Cytoprotective effects of geranylgeranylacetone against retinal photooxidative damage. |
| Q81575783 | Cytosolic, mitochondrial thioredoxins and thioredoxin reductases in Arabidopsis thaliana |
| Q43615230 | Differential antioxidant enzyme activities and glutathione content between rat and rabbit conceptuses |
| Q57491820 | Diphthamide affects selenoprotein expression: Diphthamide deficiency reduces selenocysteine incorporation, decreases selenite sensitivity and pre-disposes to oxidative stress |
| Q34271205 | Disturbed flow enhances inflammatory signaling and atherogenesis by increasing thioredoxin-1 level in endothelial cell nuclei |
| Q41312477 | Disulfide Bond-mediated multimerization of Ask1 and its reduction by thioredoxin-1 regulate H(2)O(2)-induced c-Jun NH(2)-terminal kinase activation and apoptosis |
| Q36734783 | EM23, A Natural Sesquiterpene Lactone from Elephantopus mollis, Induces Apoptosis in Human Myeloid Leukemia Cells through Thioredoxin- and Reactive Oxygen Species-Mediated Signaling Pathways |
| Q34065084 | Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant |
| Q34134433 | Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression |
| Q38507547 | Emerging role of alpha-lipoic acid in the prevention and treatment of bone loss |
| Q35849729 | Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species |
| Q44904499 | Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia |
| Q40938547 | Expression of peroxiredoxins and thioredoxins in the mouse spinal cord during embryonic development |
| Q54638022 | Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophages. |
| Q91653969 | Extracellular vesicle-mediated macrophage activation: An insight into the mechanism of thioredoxin-mediated immune activation |
| Q39806627 | FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism |
| Q39153991 | Fluorescent silver(I) and gold(I)-N-heterocyclic carbene complexes with cytotoxic properties: mechanistic insights |
| Q21710698 | Free radicals and antioxidants in normal physiological functions and human disease |
| Q40782321 | Functional analyses of two alternative isoforms of the transcription factor Pax-5. |
| Q43567856 | Further analysis of the interactions between the Brassica S receptor kinase and three interacting proteins (ARC1, THL1 and THL2) in the yeast two-hybrid system. |
| Q27317372 | Generation of Double-Labeled Reporter Cell Lines for Studying Co-Dynamics of Endogenous Proteins in Individual Human Cells |
| Q35020381 | Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes |
| Q54580356 | Hindlimb unloading decreases thioredoxin-related antioxidant proteins and increases thioredoxin-binding protein-2 in rat skeletal muscle. |
| Q26863138 | Human AP endonuclease 1: a potential marker for the prediction of environmental carcinogenesis risk |
| Q44002073 | Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops |
| Q28260396 | Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein |
| Q92354372 | Identification and Characterization of an OSH1 Thiol Reductase from Populus Trichocarpa |
| Q24299385 | Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa. New insights into the specificity of thioredoxin function |
| Q33317099 | Identification of a subunit of NADH-dehydrogenase as a p49/STRAP-binding protein |
| Q47612362 | Immunohistochemical determination of thioredoxin and glutaredoxin distribution in the human cervix, and possible relation to cervical ripening. |
| Q28270308 | Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1 |
| Q36852765 | In vitro susceptibility of thioredoxins and glutathione to redox modification and aging-related changes in skeletal muscle. |
| Q33883771 | Increased inflammatory signaling and lethality of influenza H1N1 by nuclear thioredoxin-1. |
| Q36752674 | Increased nuclear thioredoxin-1 potentiates cadmium-induced cytotoxicity |
| Q44620594 | Induction of apoptosis without redox catastrophe by thioredoxin-inhibitory compounds |
| Q43719703 | Induction of thioredoxin by ultraviolet-A radiation prevents oxidative-mediated cell death in human skin fibroblasts. |
| Q34274405 | Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy |
| Q35045262 | Inhibition of lipopolysaccharide‐inducible nitric oxide synthase, TNF‐α and COX‐2 expression by sauchinone effects on I‐κBα phosphorylation, C/EBP and AP‐1 activation |
| Q38032332 | Interacting with thioredoxin-1--disease or no disease? |
| Q39830618 | Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells |
| Q34758053 | Interactions of apurinic/apyrimidinic endonuclease with a redox inhibitor: evidence for an alternate conformation of the enzyme |
| Q40707164 | Intracellular redox regulation by a cystine derivative suppresses UV-induced NF-kappa B activation |
| Q47068703 | Lifespan decrease in a Caenorhabditis elegans mutant lacking TRX-1, a thioredoxin expressed in ASJ sensory neurons |
| Q36406300 | Mechanisms of liver injury. III. Role of glutathione redox status in liver injury |
| Q42157756 | Metallothionein modulates lipopolysaccharide-stimulated tumour necrosis factor expression in mouse peritoneal macrophages |
| Q46052794 | Mitochondrial and nuclear localization of a novel pea thioredoxin: identification of its mitochondrial target proteins. |
| Q31969223 | Modulation of exogenous and endogenous levels of thioredoxin in human skin fibroblasts prevents DNA damaging effect of ultraviolet A radiation. |
| Q34547638 | Modulation of signaling mechanisms in the heart by thioredoxin 1. |
| Q40238594 | Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin |
| Q40685055 | Murine serpin 2A is a redox-sensitive intracellular protein. |
| Q36637889 | Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance |
| Q73731634 | N-acetylcysteine suppresses TNF-induced NF-kappaB activation through inhibition of IkappaB kinases |
| Q31911355 | NF-kappaB activation by N-CAM and cytokines in astrocytes is regulated by multiple protein kinases and redox modulation |
| Q88968262 | NF-κB in Oxidative Stress |
| Q46557625 | Neuroprotection of ischemic preconditioning is mediated by thioredoxin 2 in the hippocampal CA1 region following a subsequent transient cerebral ischemia |
| Q39726102 | Neuroprotective effect of overexpression of thioredoxin on photoreceptor degeneration in Tubby mice |
| Q35078431 | Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization |
| Q40062726 | Novel anti-oxidative role of calreticulin in protecting A549 human type II alveolar epithelial cells against hypoxic injury |
| Q24316248 | Nuclear and cytoplasmic peroxiredoxin-1 differentially regulate NF-kappaB activities |
| Q40798546 | Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. |
| Q43891584 | Nuclear factor kappaB (NF-kappaB) activation by hydrogen peroxide in human epidermal keratinocytes and the restorative effect of interleukin-10. |
| Q36895504 | Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis |
| Q36992284 | Nuclear glutaredoxin 3 is critical for protection against oxidative stress-induced cell death |
| Q43955978 | Overexpressed thioredoxin compensates Fanconi anemia related chromosomal instability |
| Q40506655 | Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation. |
| Q40690197 | Overexpression of redox factor-1 protects against postischemic liver injury by reducing oxidative stress and NF-kappa B activity |
| Q44419364 | Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice |
| Q44635825 | Overexpression of thioredoxin reductase 1 regulates NF‐κB activation |
| Q47735888 | Oxidant-injured airway epithelial cells upregulate thioredoxin but do not produce interleukin-8. |
| Q40647018 | Oxidation of nuclear thioredoxin during oxidative stress |
| Q38645501 | Oxidative Stress Gene Expression Profile Correlates with Cancer Patient Poor Prognosis: Identification of Crucial Pathways Might Select Novel Therapeutic Approaches. |
| Q30630953 | Oxidative status interactome map: towards novel approaches in experiment planning, data analysis, diagnostics and therapy |
| Q54491753 | Oxidative status shifts in uterine cervical incompetence patients. |
| Q35537579 | Oxidative stress and airway inflammation in severe exacerbations of COPD. |
| Q38069883 | Oxidative stress and antioxidant defense |
| Q42355782 | Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma |
| Q59806695 | Oxidative stress: therapeutic approaches for cervical cancer treatment |
| Q96027843 | Paracrine regulation and improvement of β-cell function by thioredoxin |
| Q91781531 | Polydatin Attenuates Neuronal Loss via Reducing Neuroinflammation and Oxidative Stress in Rat MCAO Models |
| Q40757339 | Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappaBalpha phosphorylation and of p65 nuclear translocation in macrophages |
| Q36990120 | Priming donor lungs with thioredoxin-1 attenuates acute allograft injury in a rat model of lung transplantation |
| Q38955745 | Protective effects of oral administration of yeast thioredoxin against gastric mucosal injury |
| Q46830962 | Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis |
| Q34426698 | Proteomic and systems biology analysis of monocytes exposed to securinine, a GABA(A) receptor antagonist and immune adjuvant |
| Q40815579 | Rac1 activity is required for the activation of hypoxia-inducible factor 1. |
| Q36734074 | Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies |
| Q47159669 | Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes |
| Q29619367 | Reactive oxygen species, antioxidants, and the mammalian thioredoxin system |
| Q97644595 | Redox Regulation of PPARγ in Polarized Macrophages |
| Q34089741 | Redox Responses in Patients with Sepsis: High Correlation of Thioredoxin-1 and Macrophage Migration Inhibitory Factor Plasma Levels |
| Q37081874 | Redox compartmentalization in eukaryotic cells |
| Q35707262 | Redox control of signal transduction, gene expression and cellular senescence |
| Q34110120 | Redox control systems in the nucleus: mechanisms and functions |
| Q40726056 | Redox factor-1: an extra-nuclear role in the regulation of endothelial oxidative stress and apoptosis |
| Q33830130 | Redox regulation of DNA repair: implications for human health and cancer therapeutic development |
| Q35212091 | Redox regulation of cell growth and cell death |
| Q33649846 | Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart |
| Q35764015 | Redox regulation of genome stability by effects on gene expression, epigenetic pathways and DNA damage/repair. |
| Q34658995 | Redox regulation of stress signals: possible roles of dendritic stellate TRX producer cells (DST cell types). |
| Q33644327 | Redox regulation of tumor necrosis factor signaling |
| Q34237228 | Redox sensing: orthogonal control in cell cycle and apoptosis signalling |
| Q37446110 | Redox signaling in cardiovascular health and disease. |
| Q46304317 | Redox stress and signaling during vertebrate embryonic development: Regulation and responses. |
| Q34074762 | Redox systems of the cell: possible links and implications |
| Q46284091 | Redox-Sensitive Innate Immune Pathways During Macrophage Activation in Type 1 Diabetes |
| Q40808041 | Redox-sensitive transactivation of epidermal growth factor receptor by tumor necrosis factor confers the NF-kappa B activation. |
| Q61818422 | Redoxins as gatekeepers of the transcriptional oxidative stress response |
| Q27026075 | Regulation of cell survival and death by pyridine nucleotides |
| Q37168364 | Regulation of circadian clocks by redox homeostasis |
| Q34127214 | Regulation of inflammation by selenium and selenoproteins: impact on eicosanoid biosynthesis |
| Q39640507 | Regulation of the activity of the tumor suppressor PTEN by thioredoxin in Drosophila melanogaster |
| Q34108036 | Regulatory roles of thioredoxin in oxidative stress-induced cellular responses |
| Q28390011 | Renoprotective Effect of Lactoferrin against Chromium-Induced Acute Kidney Injury in Rats: Involvement of IL-18 and IGF-1 Inhibition |
| Q43586931 | Resolution, detection, and characterization of redox conformers of human HSF1. |
| Q38809883 | Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity |
| Q37445518 | Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease |
| Q40763940 | Reversible inhibition of hypoxia-inducible factor 1 activation by exposure of hypoxic cells to the volatile anesthetic halothane |
| Q44649069 | Roles of TRP14, a Thioredoxin-related Protein in Tumor Necrosis Factor-α Signaling Pathways |
| Q38328125 | Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity |
| Q36027216 | S-glutathionylation of cysteine 99 in the APE1 protein impairs abasic endonuclease activity. |
| Q34827002 | S-nitrosylation: physiological regulation of NF-kappaB |
| Q38434797 | Salicylideneamino-2-thiophenol modulates nuclear factor-κB through redox regulation during the aging process |
| Q24336442 | Salmonella type III secretion effector SlrP is an E3 ubiquitin ligase for mammalian thioredoxin |
| Q78654225 | Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease |
| Q42438304 | Signaling role of intracellular iron in NF-kappaB activation |
| Q36511645 | Significance of wine and resveratrol in cardiovascular disease: French paradox revisited |
| Q50090745 | Silencing thioredoxin1 exacerbates damage of astrocytes exposed to OGD/R by aggravating apoptosis through the Actin-Ras2-cAMP-PKA pathway |
| Q39859930 | Sodium selenite increases the activity of the tumor suppressor protein, PTEN, in DU-145 prostate cancer cells |
| Q37784233 | Solar radiation induced skin damage: review of protective and preventive options. |
| Q44126941 | Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. |
| Q36118494 | Specificity in reactive oxidant signaling: think globally, act locally |
| Q44689334 | Suboptimal action of NF-kappaB in Fanconi anemia cells results from low levels of thioredoxin |
| Q42519880 | Suppressed proliferative response of spleen T cells from metallothionein null mice |
| Q39483515 | Suppressive effect of administration of recombinant human thioredoxin on cutaneous inflammation caused by UV. |
| Q36670728 | TXNIP/TRX/NF-κB and MAPK/NF-κB pathways involved in the cardiotoxicity induced by Venenum Bufonis in rats |
| Q37781872 | Targeting tissue oxidative damage by means of cell signaling modulators: The antioxidant concept revisited |
| Q90161821 | The Role of NFκB in Healthy and Preeclamptic Placenta: Trophoblasts in the Spotlight |
| Q42611767 | The ThioredoxinT and deadhead gene pair encode testis- and ovary-specific thioredoxins in Drosophila melanogaster |
| Q33741157 | The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase |
| Q28389296 | The complexity of the Nrf2 pathway: beyond the antioxidant response |
| Q28344966 | The conserved redox-sensitive cysteine residue of the DNA-binding region in the c-Rel protein is involved in the regulation of the phosphorylation of the protein |
| Q36452887 | The effects of acrolein on the thioredoxin system: implications for redox-sensitive signaling |
| Q28397704 | The effects of chromium(VI) on the thioredoxin system: implications for redox regulation |
| Q35123800 | The emerging role of the thioredoxin system in angiogenesis |
| Q40677508 | The nonclassic secretion of thioredoxin is not sensitive to redox state |
| Q38166575 | The nrf1 and nrf2 balance in oxidative stress regulation and androgen signaling in prostate cancer cells |
| Q34307796 | The respiratory burst response of surface-adhering leukocytes. A key to tissue engineering |
| Q42440994 | The role and regulation of Trxl, a cytosolic thioredoxin in Schizosaccharomyces pombe |
| Q42494763 | The thioredoxin system in aging muscle: key role of mitochondrial thioredoxin reductase in the protective effects of caloric restriction? |
| Q34274107 | The thioredoxin system—From science to clinic |
| Q42977529 | Thiol redox transitions by thioredoxin and thioredoxin-binding protein-2 in cell signaling |
| Q36994322 | Thiol-independent action of mitochondrial thioredoxin to support the urea cycle of arginine biosynthesis in Schizosaccharomyces pombe |
| Q42322950 | Thioredoxin (Trxo1) interacts with proliferating cell nuclear antigen (PCNA) and its overexpression affects the growth of tobacco cell culture |
| Q41917030 | Thioredoxin 1 modulates apoptosis induced by bioactive compounds in prostate cancer cells |
| Q35222209 | Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies. |
| Q36869643 | Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate Cancer |
| Q38166568 | Thioredoxin and Cancer: A Role for Thioredoxin in all States of Tumor Oxygenation |
| Q54548898 | Thioredoxin and glutaredoxin isoforms. |
| Q39822905 | Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells |
| Q24683258 | Thioredoxin and ventricular remodeling |
| Q38238628 | Thioredoxin as a putative biomarker and candidate target in age-related immune decline |
| Q40878106 | Thioredoxin facilitates the induction of heme oxygenase-1 in response to inflammatory mediators |
| Q42483952 | Thioredoxin interacting protein expression in the urinary sediment associates with renal function decline in type 1 diabetes |
| Q44823824 | Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma |
| Q28207541 | Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA |
| Q46305740 | Thioredoxin promotes survival signaling events under nitrosative/oxidative stress associated with cancer development |
| Q78758510 | Thioredoxin reductase 1 expression in colon cancer: discrepancy between in vitro and in vivo findings |
| Q39148737 | Thioredoxin reductase is essential for the survival of Plasmodium falciparum erythrocytic stages |
| Q53591061 | Thioredoxin reductase is required for growth and regulates entry into culmination of Dictyostelium discoideum. |
| Q44127151 | Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation |
| Q34049898 | Thioredoxin reductase two modes of catalysis have evolved |
| Q36980967 | Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages |
| Q40598051 | Thioredoxin, a regulator of gene expression |
| Q50964992 | Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications. |
| Q37536634 | Thioredoxin-mediated denitrosylation regulates cytokine-induced nuclear factor κB (NF-κB) activation |
| Q34483693 | Thioredoxin-mediated negative autoregulation of peroxisome proliferator-activated receptor alpha transcriptional activity |
| Q40751281 | Thioredoxin-mediated redox control of human T cell lymphotropic virus type I (HTLV-I) gene expression |
| Q34566282 | Thioredoxin. Overview |
| Q34578655 | Thioredoxins in chloroplasts |
| Q36646928 | Thioredoxins, glutaredoxins, and glutathionylation: new crosstalks to explore. |
| Q28389739 | Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling |
| Q39502076 | Transactivation of gene expression by NF-κB is dependent on thioredoxin reductase activity |
| Q23919656 | Transcriptional responses to oxidative stress: pathological and toxicological implications |
| Q46479904 | Triggering apoptosis in cancer cells with an analogue of cribrostatin 6 that elevates intracellular ROS. |
| Q39240834 | Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials |
| Q28080723 | TrxR1 as a potent regulator of the Nrf2-Keap1 response system |
| Q52690142 | Two essential Thioredoxins mediate apicoplast biogenesis, protein import, and gene expression in Toxoplasma gondii. |
| Q99634237 | Txn2 haplodeficiency does not affect cochlear antioxidant defenses or accelerate the progression of cochlear cell loss or hearing loss across the lifespan |
| Q33942829 | Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma |
| Q73713267 | Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats |
| Q55258926 | Uric acid disrupts hypochlorous acid production and the bactericidal activity of HL-60 cells. |
| Q30844698 | Visualization of aging-associated chromatin alterations with an engineered TALE system |
| Q28581284 | Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin |
| Q28384223 | When NRF2 talks, who's listening? |
| Q31527614 | c-Jun NH2-terminal kinase-mediated redox-dependent degradation of IkappaB: role of thioredoxin in NF-kappaB activation |
| Q36771883 | γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers |
Search more.